These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1313 related articles for article (PubMed ID: 32588943)

  • 21. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa.
    Giorgino F; Bhana S; Czupryniak L; Dagdelen S; Galstyan GR; Janež A; Lalić N; Nouri N; Rahelić D; Stoian AP; Raz I
    Diabetes Res Clin Pract; 2021 Feb; 172():108617. PubMed ID: 33310175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excess body weight is an independent risk factor for severe forms of COVID-19.
    Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S
    Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 24. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
    James PT; Ali Z; Armitage AE; Bonell A; Cerami C; Drakesmith H; Jobe M; Jones KS; Liew Z; Moore SE; Morales-Berstein F; Nabwera HM; Nadjm B; Pasricha SR; Scheelbeek P; Silver MJ; Teh MR; Prentice AM
    J Nutr; 2021 Jul; 151(7):1854-1878. PubMed ID: 33982105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling obesity during the COVID-19 pandemic.
    Akirov A; Cahn A; Del Prato S; Home P; Van Gaal L; Chan J; Ning G; Raz I
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3393. PubMed ID: 32797666
    [No Abstract]   [Full Text] [Related]  

  • 26. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes.
    Jin S; Hu W
    Front Endocrinol (Lausanne); 2021; 12():602735. PubMed ID: 33995267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis.
    Zhao X; Gang X; He G; Li Z; Lv Y; Han Q; Wang G
    Front Endocrinol (Lausanne); 2020; 11():595109. PubMed ID: 33408692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
    Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
    Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
    Wu ZH; Tang Y; Cheng Q
    Acta Diabetol; 2021 Feb; 58(2):139-144. PubMed ID: 32583078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021.
    Kompaniyets L; Pennington AF; Goodman AB; Rosenblum HG; Belay B; Ko JY; Chevinsky JR; Schieber LZ; Summers AD; Lavery AM; Preston LE; Danielson ML; Cui Z; Namulanda G; Yusuf H; Mac Kenzie WR; Wong KK; Baggs J; Boehmer TK; Gundlapalli AV
    Prev Chronic Dis; 2021 Jul; 18():E66. PubMed ID: 34197283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
    Corrao S; Pinelli K; Vacca M; Raspanti M; Argano C
    Front Endocrinol (Lausanne); 2021; 12():609470. PubMed ID: 33868163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imminent risk of COVID-19 in diabetes mellitus and undiagnosed diabetes mellitus patients.
    John JE; John NA
    Pan Afr Med J; 2020; 36():158. PubMed ID: 32874422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.
    Kompaniyets L; Agathis NT; Nelson JM; Preston LE; Ko JY; Belay B; Pennington AF; Danielson ML; DeSisto CL; Chevinsky JR; Schieber LZ; Yusuf H; Baggs J; Mac Kenzie WR; Wong KK; Boehmer TK; Gundlapalli AV; Goodman AB
    JAMA Netw Open; 2021 Jun; 4(6):e2111182. PubMed ID: 34097050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019.
    Fishkin T; Goldberg MD; Frishman WH
    Cardiol Rev; 2021 Nov-Dec 01; 29(6):292-295. PubMed ID: 34261900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
    Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
    S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview.
    Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA
    Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.